Germantown, TN, United States of America

Taosheng Chen

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Memphis, TN (US) (2022)
  • Germantown, TN (US) (2017 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Taosheng Chen

Introduction

Taosheng Chen is a prominent inventor based in Germantown, TN, known for his significant contributions to the field of biomedical research. With a total of nine patents to his name, Chen has made remarkable strides in developing methods for treating and preventing various health conditions.

Latest Patents

Among his latest patents, Chen has developed a method for identifying modulators of G3BP activity. This innovative approach involves determining whether a compound can modulate the interaction between the N-terminal Nuclear Transport Factor 2-like (NTF2L) domain of G3BP and the FGDF peptide of ubiquitin-specific protease 10 (USP10) or non-structural protein 3 (nsP3). Additionally, he has patented methods for the prevention and treatment of hearing loss using Oseltamivir. This patent reveals that Oseltamivir can be used as an active agent to treat and prevent hearing impairments, showcasing its effectiveness against noise-induced and cisplatin-induced hearing loss.

Career Highlights

Throughout his career, Taosheng Chen has worked with esteemed organizations such as St. Jude Children's Research Hospital and Ting Therapeutics LLC. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Chen has collaborated with notable colleagues, including Wenwei Lin and Jian Zuo, further enhancing the impact of his research and innovations.

Conclusion

Taosheng Chen's contributions to biomedical research through his patents and collaborations highlight his role as a leading inventor in the field. His innovative methods for treating hearing loss and identifying modulators of G3BP activity demonstrate his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…